Real world time trends in antithrombotic treatment for newly diagnosed atrialfibrillation in China: reports from the GLORIA-AF Phase III registry: Trends in antithrombotic therapy use in China.
Screening for undiagnosed atrialfibrillation using a single-lead electrocardiogram at primary care visits: patient uptake and practitioner perspectives from the VITAL-AF trial.
Retrospective Evaluation of P-wave Dispersion on ECG in Terms of AtrialFibrillation Dispersion in Patients Using Alpha-blockers for Lower Urinary Tract Symptoms.
Alt Üriner Sistem Semptomları Nedeni ile Alfa-bloker Kullanan Hastalarda EKG'de P-dalga Dispersiyonunun Atriyal Fibrilasyon Dispersiyonu Açısından Retrospektif Olarak Değerlendirilmesi.
Characterization and identification of atrialfibrillation drivers in patients with nonparoxysmal atrialfibrillation using simultaneous amplitude frequency electrogram transform.
Increasing time between first diagnosis of atrialfibrillation and catheter ablation adversely affects long‐term outcomes in patients with and without structural heart disease.
Spatial relationship of localized sources of persistent atrialfibrillation identified by a unipolar‐based automated algorithm to complex fractionated atrial electrocardiograms and atrial low voltage areas.
Real-world data in primary care: validation of diagnosis of atrialfibrillation in primary care electronic medical records and estimated prevalence among consulting patients'.
Generalisability of and lessons learned from a mixed-methods study conducted in three low- and middle-income countries to identify care pathways for atrialfibrillation.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies